Similar articles

• Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.

  Nordmann AJ, Briel M, Bucher HC. Nordmann AJ, et al. Eur Heart J. 2006 Dec;27(23):2784-814. doi: 10.1093/eurheartj/ehl282. Epub 2006 Oct 4. Eur Heart J. 2006. PMID: 17020889 Review.
• Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.

  Dibra A, Kastrati A, Alfonso F, Seyfarth M, Pérez-Vizcayno MJ, Mehilli J, Schömig A. Dibra A, et al. J Am Coll Cardiol. 2007 Feb 6;49(5):616-23. doi: 10.1016/j.jacc.2006.10.049. Epub 2006 Dec 4. J Am Coll Cardiol. 2007. PMID: 17276188
• Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.

  Ahmed WH. Ahmed WH. Expert Rev Med Devices. 2007 Mar;4(2):117-20. doi: 10.1586/17434440.4.2.117. Expert Rev Med Devices. 2007. PMID: 17359218 Review.
• One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent in patients with diabetes mellitus.

  Finn AV, Gold HK. Finn AV, et al. Circulation. 2004 Sep 21;110(12):e318-9; author reply e318-9. doi: 10.1161/01.CIR.0000142207.05425.76. Circulation. 2004. PMID: 15381668 No abstract available.
• Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.

  Mehilli J, Kastrati A, Wessely R, Dibra A, Hausleiter J, Jaschke B, Dirschinger J, Schömig A; Intracoronary Stenting and Angiographic Restenosis--Test Equivalence Between 2 Drug-Eluting Stents (ISAR-TEST) Trial Investigators. Mehilli J, et al. Circulation. 2006 Jan 17;113(2):273-9. doi: 10.1161/CIRCULATIONAHA.105.575977. Epub 2006 Jan 3. Circulation. 2006. PMID: 16391155 Clinical Trial.